News About: Pharm. Industry
Phase IV clinical trial result of Shin Poong Pharm’s Pyramax announced at conference in Africa
In the Satellite symposium at the Pan African Malaria Conference – Multilateral Initiatives on Malaria(MM) at Dakar, Senegal, Shin Poong Pharm(CEO Jae-Man Yoo) announced the Pyramax’s clinical trial result.
Held arou...
Pharmbio Korea signs exclusive license agreement of new opioid painkiller with U.S.
Pharmbio Korea(Chairman Bong-Gil Nam) announced on the 14th that the company signed an exclusive license agreement for development and commercialization of Oliceridine, an opioid, intravenous injection being developed...
SK Chemicals’ joint sales and marketing agreement of SKY Zoster with Daewoong
‘SKY Zoster,’ the first shingles vaccine developed by an Korean pharmaceutical company and become a blockbuster medicinal drug with collective sales of KRW 10 billion this year, will have more active marketing activit...
‘Big 5’ pharmas’ business performance in 1st quarter with joy and sorrow
Yakup Shinmoon(www.yakup.com) analyzed business performances that the ‘Big 5’ pharmaceutical companies made in the 1st quarter of 2018, their sales and operating profits were increased by 2.9% and 67% respectively.
A...
“Korean pharma industry must put more strength into commercialization to enter global market”
It was criticized the Korean pharmaceutical industry needed localized commercialization and partnership as things to improve when entering the global market.
Tim Reiner, Business Development Head at Mundi Pharma, dia...
Merck’s 23 immune & oncology pipelines accelerated towards commercialization
Merck, a global pharmaceutical company, showed a strong will to develop new drugs related to oncology by revealing immune and oncology pipelines being developed by the company.
Professor Morihiro Watanabe taking in c...
JW Pharmaceutical to recruit new employees using AI interviews
JW Pharmaceutical will recruit new employees using artificial intelligence(AI) interviewees.
JW Pharmaceutical(CEO Jae-Kwang Jeon & Young-Sup Shin) announced on the 10th that the company would use the AI recruitment ...
MFDS creates warning about Shin Poong Pharm’s ‘Inisia Tab’
Warning statements about having chances to occur liver damage and liver failure will be added in the drug instruction for ‘Inisia Tab(generic name: ulipristal),’ a Shin Poong Pharm’s uterine fibroids treatment.
The M...
Trending ‘Flexible Working Hour System’ in pharma and distribution industries over 52 hours a week
While pharmacists are busy preparing responsive actions with the 52 working hours a week, the ‘flexible work system’ has been raised in the pharmaceutical distribution industry.
According to the distribution industry...
‘Hyalrheuma,’ Hanmi Pharm’s arthritis treatment acquires FDA approval
Hanmi Pharm(CEO Sae-Chang Kwon & Jong-Soo Woo) announced on the 9th that the company has acquired approval of ‘Hyalrheuma Inj,’ a self-developed arthritis treatment, from the U.S. FDA for the first time as a Korean co...
